AI can help improve breast cancer risk predictions, study finds

  • 📰 CBSNews
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A new study is showing yet another way artificial intelligence is entering the medical field — and potentially improving existing practices for predicting breast cancer risk.

artificial intelligence is entering the medical fieldThe study, which was published Tuesday in Radiology, a peer-reviewed journal, found AI algorithms outperformed the standard clinical risk model for predicting the five-year risk forRisk models like the Breast Cancer Surveillance Consortium clinical risk score, which use self-reported and other patient information including age, family history and more, are typically used to calculate a woman's risk of breast cancer.

In the retrospective study, thousands of mammograms were analyzed, and risk scores for breast cancer over a five-year period were generated by five AI algorithms. Those scores were then compared to each other and the BCSC clinical risk score.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 87. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shortage of common cancer-fighting drugs adding new stress to cancer diagnosisThe drugs in short supply include the two main choices for treating breast cancer, which is the most common type of cancer.
Source: PennLive - 🏆 463. / 53 Read more »

Chemo Avoidance Pays Off for Some Women With HER2+ Early BCNearly all patients who were diverted from chemotherapy prior to surgery for HER2-positive early breast cancer survived without cancer recurrence for 3 years, according to new findings from a phase 2 trial. ASCO23 BCSM
Source: Medscape - 🏆 386. / 55 Read more »

Bristol study finds heart attack risk in osteoporosis drugNew research highlights potential safety concerns around women taking the medicine Evenity.
Source: bbchealth - 🏆 143. / 63 Read more »